Holding(s) in Company

Summary by AI BETAClose X

Pentwater Capital Management LP has notified Renalytix PLC of a change in its major holding, reporting a combined total of 11.344239% of voting rights and financial instruments. This comprises 5.512339% of voting rights attached to shares and 5.831900% through financial instruments, specifically a swap with cash settlement. This represents an increase from their previous notification where they held 9.243438% in total. The notification date for this change is September 8, 2026.

Disclaimer*

UK 100

Latest directors dealings